premalignos

Premalignos, or premalignant conditions, refer to tissue changes that confer an increased risk of developing cancer but are not themselves invasive malignancies. While the term premalignos is occasionally used, most medical sources describe these as premalignant lesions or premalignant conditions. They are characterized by cellular or architectural abnormalities such as dysplasia, hyperplasia with atypia, or metaplasia in an epithelium.

The progression of a premalignant lesion, when it occurs, is commonly described along a sequence from normal tissue to dysplasia and then to carcinoma in situ before invasive cancer. However, not all premalignant conditions progress; some remain stable for long periods or even regress, especially with risk factor modification and treatment of the lesion.

Common examples span several organ systems. Cervical intraepithelial neoplasia reflects premalignant changes in the cervix associated with human papillomavirus infection. Oral premalignant lesions include leukoplakia and erythroplakia. Actinic keratosis is a premalignant skin lesion linked to sun exposure. Barrett’s esophagus can acquire dysplasia and progress toward esophageal adenocarcinoma. In the gastrointestinal tract, adenomatous polyps of the colon and gastric intestinal metaplasia with dysplasia are also considered premalignant.

Detection typically relies on targeted screening and biopsy to determine severity and grade. Management ranges from careful surveillance to local excision or ablation, depending on site, histology, and patient risk factors. Prevention focuses on risk reduction, including vaccination (e.g., HPV), smoking cessation, and avoidance of known carcinogens.